In March 2025, the company declared new designs for the direct-to-shopper providing of its Wegovy weight loss drug. The company recognized a brand new pharmacy, referred to as NovoCare, which would charge buyers $499 monthly for usage of the drug, lower than fifty percent the cost of the drug via other pharmaceutical distribution networks.[fifty th